Kura Oncology (KURA) Tops Q2 EPS by 1c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.53), $0.01 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Investing.com’s stocks of the week
• AiRWA receives Nasdaq deficiency notice over late 10-K filing